Tim Vanuytsel

Appearances

GLEPAGLUTIDE, A LONG-ACTING GLP-2 ANALOG, SIGNIFICANTLY REDUCES NEED FOR PARENTERAL SUPPORT IN PATIENTS WITH SHORT BOWEL SYNDROME: RESULTS OF EASE SBS-1, A RANDOMIZED, DOUBLE-BLIND, 24-WEEK PHASE 3 TRIAL
Date
May 8, 2023
BACKGROUND: Marine omega-3 fatty acids (MO3FAs) - which include eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) - are fatty acids that have anti-inflammatory properties, reducing C-reactive protein (CRP) and proinflammatory cytokines…
Presenter
David F. Mercer
Speakers
Tim Vanuytsel
Sukanya Subramanian
Francisca Joly
Geert Wanten
Georg Lamprecht
Marek Kunecki
Farooq Rahman
Birgitte Biilmann Rønn
Lykke Bjerglund Graff
Mark Berner-Hansen
Ulrich Pape
Palle Jeppesen
COMPARISON OF THE PREVALENCE OF MEAL-RELATED NAUSEA IN DIFFERENT FUNCTIONAL DYSPEPSIA SUBGROUPS
Date
May 21, 2024
According to the ROME IV criteria, Functional dyspepsia (FD) can be subdivided into PDS (postprandial distress syndrome) with meal-related symptoms such as early satiation and postprandial fullness and EPS (epigastric pain syndrome) with meal-unrelated complaints such as epigastric pain or burning…
Presenter
Bert Broeders
Speakers
Florencia Carbone
Cedric Van de Bruaene
Tim Vanuytsel
Jan Tack